Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

Completed · Phase 2

Conditions studied: Dry Eye Disease

In brief

The purpose of this study is to investigate the safety and efficacy of an ophthalmic solution in dry eye disease.

Key facts

Study ID

NCT00758784

Run by

Bausch & Lomb Incorporated

People needed

38

Starts

2008-08-13

Expected to finish

2009-01-14

Last updated by the study team

2020-09-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects 18 years of age or older

You may not qualify if…

• No active ocular conditions of disease

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.